Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Study on Oxymatrine-Based Research from 2001 to 2022: A Bibliometric Analysis
ACS Omega ( IF 3.7 ) Pub Date : 2024-02-13 , DOI: 10.1021/acsomega.3c07880 Xu Lan 1 , Yao Chen 2 , Jia-jia Duan 1 , Jia Xu 1
ACS Omega ( IF 3.7 ) Pub Date : 2024-02-13 , DOI: 10.1021/acsomega.3c07880 Xu Lan 1 , Yao Chen 2 , Jia-jia Duan 1 , Jia Xu 1
Affiliation
|
Oxymatrine is a quinolizidine alkaloid mainly derived from Kushen; it possesses various therapeutic effects, such as organ- and tissue-protective, anticancer, and antiviral effects. The research directions for oxymatrine remain broad. In order to explore the overall status of oxymatrine-based research, we carried out a bibliometric analysis to summarize the oxymatrine-based, English-written studies published in the past 22 years. In total, 267 studies were included, most of which were original. The number of annual studies slowly increased with some fluctuations. Other than China, 11 different countries conducted studies on oxymatrine; the variety in the country of origin of these publications is presented as a recently increasing trend. Many affiliates and researchers have participated in oxymatrine-based research. Various treatment mechanisms involving different oxymatrine pathways have led to research in a wide range of fields, being published in numerous journals. Two particularly popular research fields related to oxymatrine involved anticancer and anti-inflammation. From this research, we concluded that with increasing and continuous in-depth studies, more therapeutic effects and mechanisms will be elucidated, and oxymatrine may present as a viable option for the treatment of additional diseases.
更新日期：2024-02-13
京公网安备 11010802027423号